首页 >
法规速递
-
国家药监局关于修订小儿肺咳颗粒、生血宝制剂、血塞通口服制剂说明书的公告（2023年第38号）-2023/4/13
2023-04-14查看详情 > -
《药品经营和使用质量监督管理办法》解读（一）-2023/10/13
2023-10-16查看详情 > -
国家药监局关于30批次不符合规定化妆品的通告（2025年第3号）-2025/1/9
2025-01-09查看详情 > -
Page: Procedures for monograph and list entry establishment-2025/2/14
2025-02-18查看详情 > -
Page: Worksharing: questions and answers-2025/3/25
2025-03-26查看详情 > -
Document: Organisation chart: Information Management-2025/4/28
2025-04-29查看详情 > -
Document: Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) annual activity report 2024-2025/6/6
2025-06-09查看详情 > -
Page: Clinical pharmacology and pharmacokinetics: questions and answers-2025/7/15
2025-07-16查看详情 > -
Document: Questions and answers on the outcome of assessment on use of Revolade in treatment of severe aplastic anaemia in children-2025/8/25
2025-08-26查看详情 > -
Document: Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level-2025/10/1
2025-10-08查看详情 >
